Orleans Capital Management Corp Merck & Co., Inc. Transaction History

Orleans Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 19, 2021	SELL	$71.77 - $79.65 $252,630 - $280,368	-3,520 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $1.47 Million - $1.66 Million	-20,055 Reduced 85.07%	3,520 $292,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $1.66 Million - $1.89 Million	23,575 New	23,575 $1.82 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $1.58 Million - $2.19 Million	-24,980 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $5,430 - $6,127	70 Added 0.28%	24,980 $2.27 Million
Q3 2019 Nov 15, 2019	BUY	$76.08 - $82.93 $27,388 - $29,854	360 Added 1.47%	24,910 $2.1 Million
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $374,342 - $437,322	5,360 Added 27.93%	24,550 $2.06 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $1.34 Million - $1.52 Million	19,190 New	19,190 $1.6 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Orleans Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Orleans Capital Management Corp with notifications on news.